hematide: Clinical Trials

3 trials of hematide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 3

Follow hematide: new trials by email Literature Review of hematide trials Research Report on hematide

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)
peginesatide - Chronic Renal Failure, Chronic Kidney Disease
Phase 2TerminatedAffymax1142006-11-012012-06-29
Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD
peginesatide - Chronic Renal Failure, Chronic Kidney Disease
Phase 2TerminatedAffymax812006-09-012012-06-29
Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease
Placebo, peginesatide - Anemia, Chronic Kidney Disease
Phase 2TerminatedAffymax172005-03-012012-12-21

Conditions studied

Anemia (3)  ·  Kidney Failure, Chronic (3)  ·  Renal Insufficiency, Chronic (3)

Sponsors

Affymax (3)

Countries

United Kingdom (2)  ·  Bulgaria (1)  ·  Poland (1)  ·  Romania (1)  ·  United States (1)

Top investigators

Vice President, Clinical Development (2)

NIH funding

2005 (1)